Rubicon Genomics Inc-医療機器分野:企業M&A・提携分析

◆英語タイトル:Rubicon Genomics Inc - Medical Equipment - Deals and Alliances Profile
◆商品コード:DATA8011202
◆発行会社(調査会社):GlobalData
◆発行日:2017年12月22日
◆ページ数:27
◆レポート言語:英語
◆レポート形式:PDF
◆納品方法:Eメール
◆対象地域:アメリカ
◆産業分野:医療機器
◆販売価格オプション(消費税別)
Single UserUSD250 ⇒換算¥37,000見積依頼/購入/質問フォーム
Site License(同一事業所内共有可)USD500 ⇒換算¥74,000見積依頼/購入/質問フォーム
Enterprisewide License(複数事業所内共有可)USD750 ⇒換算¥111,000見積依頼/購入/質問フォーム
販売価格オプションの説明はこちらでご利用ガイドはこちらでご確認いただけます。
※お支払金額は「換算金額(日本円)+消費税+配送料(Eメール納品は無料)」です。
※本体価格が¥30,000未満のレポートにつきましては、ハンドリングチャージ¥5,000が別途かかります。
※Eメールによる納品の場合、通常ご注文当日〜2日以内に納品致します。
※レポート納品後、納品日+5日以内に請求書を発行し、お客様宛に郵送しますので、請求書発行日より2ヶ月以内に振込をお願いします。
※為替レートは適宜修正・更新しております。リアルタイム更新ではありません。
※弊社H&Iグローバルリサーチ株式会社はGlobalData社の日本における正規販売代理店です。同社発行の企業調査レポートに関するお問い合わせは弊社までお願い致します。
GlobalData社の概要はこちらでご確認いただけます。



【レポートの概要】

Summary
Rubicon Genomics Inc (Rubicon Genomics), a subsidiary of the Takara Bio Group is a provider of pre-analytical amplification technologies. The company offers various types of kits for whole genome sequencing (WGS), whole exome sequencing (WES), targeted sequencing, copy number variation (CNV) analysis, Aneuploidy, circulating tumor deoxyribose nucleic acid (ctDNA) analysis, and gene expression analysis. It employs high sensitivity ligation-based amplification, and quasi-random primed linear amplification technologies in its sequencing kits. Rubicon Genomics’ sequencing kits find applications in Formalin-fixed, paraffin-embedded (FFPE) DNA sequencing, DNA sequencing, ribose nucleic acid (RNA) sequencing, pre-implantation genetic screening and diagnosis (PGS, PGD), and chromatin immunoprecipitation sequencing (ChIP-seq). Rubicon Genomics is headquartered in Ann Arbor, Michigan, the US.

Rubicon Genomics Inc – Medical Equipment – Deals and Alliances Profile provides you comprehensive data and trend analysis of the company’s Mergers and Acquisitions (M&As), partnerships and financings. The report provides detailed information on Mergers and Acquisitions, Equity/Debt Offerings, Private Equity, Venture Financing and Partnership transactions recorded by the company over a five year period. The report offers detailed comparative data on the number of deals and their value categorized into deal types, sub-sector and regions.

GlobalData derived the data presented in this report from proprietary in-house Medical eTrack deals database, and primary and secondary research.

Scope

- Financial Deals – Analysis of the company’s financial deals including Mergers and Acquisitions, Equity/Debt Offerings, Private Equity, Venture Financing and Partnerships.
- Deals by Year – Chart and table displaying information encompassing the number of deals and value reported by the company by year, for a five year period.
- Deals by Type – Chart and table depicting information including the number of deals and value reported by the company by type such as Mergers and Acquisitions, Equity/Debt Offering etc.
- Deals by Region – Chart and table presenting information on the number of deals and value reported by the company by region, which includes North America, Europe, Asia Pacific, the Middle East and Africa and South and Central America.
- Deals by Sub-sector – Chart and table showing information on the number of deals and value reported by the company, by sub-sector.
- Major Deals – Information on the company’s major financial deals. Each such deal has a brief summary, deal type, deal rationale; and deal financials and target Company’s (major public companies) key financial metrics and ratios.
- Business Description – A brief description of the company’s operations.
- Key Employees – A list of the key executives of the company.
- Important Locations and Subsidiaries – A list and contact details of key centers of operation and subsidiaries of the company.
- Key Competitors – A list of the key competitors of the company.
- Key Recent Developments – A brief on recent news about the company.

Reasons to Buy

Get detailed information on the company’s financial deals that enable you to understand the company’s expansion/divestiture and fund requirements
- The profile enables you to analyze the company’s financial deals by region, by year, by business segments and by type, for a five year period.

Understand the company’s business segments’ expansion / divestiture strategy
- The profile presents deals from the company’s core business segments’ perspective to help you understand its corporate strategy.

Access elaborate information on the company’s recent financial deals that enable you to understand the key deals which have shaped the company
- Detailed information on major recent deals includes a summary of each deal, deal type, deal rationale, deal financials and Target Company’s key financial metrics and ratios.

Equip yourself with detailed information about the company’s operations to identify potential customers and suppliers.
- The profile analyzes the company’s business structure, locations and subsidiaries, key executives and key competitors.

Stay up-to-date on the major developments affecting the company
- Recent developments concerning the company presented in the profile help you track important events.

Gain key insights into the company for academic or business research
- Key elements such as break up of deals into categories and information on detailed major deals are incorporated into the profile to assist your academic or business research needs.

Note*: Some sections may be missing if data is unavailable for the company.

【レポートの目次】

Table of Contents
Table of Contents 3
List of Tables 4
List of Figures 4
Rubicon Genomics Inc, Medical Equipment, Deals By Year, 2011 to YTD 2017 5
Rubicon Genomics Inc, Medical Equipment Deals By Type, 2011 to YTD 2017 6
Rubicon Genomics Inc, Medical Equipment, Deals By Region, 2011 to YTD 2017 7
Rubicon Genomics Inc, Medical Equipment, Deals By Market, 2011 to YTD 2017 8
Rubicon Genomics Inc, Medical Equipment, Deals Summary, 2011 to YTD 2017 9
Rubicon Genomics Inc, Medical Equipment, Deal Details 10
Venture Financing 10
Rubicon Genomics Raises USD2 Million in Venture Financing 10
Partnerships 11
Rubicon Genomics Enters Into Licensing Agreement With University Of Michigan 11
Rubicon Genomics Enters Into Distribution Agreement With GenoMax Technologies For DNA Library Prep Kits 12
Clontech Labs Enters Into Technology Integration Agreement With Rubicon Genomics 13
Fluxion Bioscience Enters Into Technology Integration Agreement With Rubicon Genomics 14
Rubicon Genomics Enters Into Technology Integration Agreement With Kreatech Diagnostics 15
New England Biolabs Enters Into Co-Marketing Agreement With Rubicon Genomics 16
PerkinElmer Enters Into Distribution Agreement With Rubicon Genomics 17
Acquisition 18
Takara Bio Acquires Rubicon Genomics for USD75 Million 18
Rubicon Genomics Inc – Key Competitors 19
Rubicon Genomics Inc – Key Employees 20
Rubicon Genomics Inc – Locations And Subsidiaries 21
Head Office 21
Recent Developments 22
Product News 22
Nov 07, 2016: Rubicon Genomics to Present Data on New Thruplex Enrichment Kit at AMP 2016 Annual Meeting; Also Named 2017 “Company to Watch” Finalist 22
Other Significant Developments 23
Dec 21, 2016: Rubicon Genomics Signs Supply Agreement With Agilent Technologies For Its PicoPLEX WGA Kit 23
Aug 17, 2016: Rubicon Genomics reports robust Sales Growth in 2016 and announces Early Access Program for Thruplex Tag-Seq Kits 24
Apr 12, 2016: Rubicon Genomics Expands Asia Distribution; 2016 AACR Data Presentation Shows Utility of ThruPLEX Plasma-seq Cell-Free NGS Libraries From Liquid Biopsies 25
Jan 11, 2016: Rubicon Genomics Adds New Distributors as Product Sales Continued to Accelerate in 2015 26
Appendix 27
Methodology 27
About GlobalData 27
Contact Us 27
Disclaimer 27

List of Tables
Rubicon Genomics Inc, Medical Equipment, Key Facts 2
Rubicon Genomics Inc, Medical Equipment, Deals Summary, 2011 to YTD 2017 2
Rubicon Genomics Inc, Medical Equipment, Deals By Year, 2011 to YTD 2017 5
Rubicon Genomics Inc, Medical Equipment Deals By Type, 2011 to YTD 2017 6
Rubicon Genomics Inc, Medical Equipment, Deals By Region, 2011 to YTD 2017 7
Rubicon Genomics Inc, Deals By Market, 2011 to YTD 2017 8
Rubicon Genomics Inc, Medical Equipment, Deals Summary, 2011 to YTD 2017 9
Rubicon Genomics Raises USD2 Million in Venture Financing 10
Rubicon Genomics Enters Into Licensing Agreement With University Of Michigan 11
Rubicon Genomics Enters Into Distribution Agreement With GenoMax Technologies For DNA Library Prep Kits 12
Clontech Labs Enters Into Technology Integration Agreement With Rubicon Genomics 13
Fluxion Bioscience Enters Into Technology Integration Agreement With Rubicon Genomics 14
Rubicon Genomics Enters Into Technology Integration Agreement With Kreatech Diagnostics 15
New England Biolabs Enters Into Co-Marketing Agreement With Rubicon Genomics 16
PerkinElmer Enters Into Distribution Agreement With Rubicon Genomics 17
Takara Bio Acquires Rubicon Genomics for USD75 Million 18
Rubicon Genomics Inc, Key Competitors 19
Rubicon Genomics Inc, Key Employees 20

★海外企業調査レポート[Rubicon Genomics Inc-医療機器分野:企業M&A・提携分析]についてメールでお問い合わせはこちら

■おすすめ企業レポート■
  • BEENOS Inc.:企業のM&A・事業提携・投資動向
    BEENOS Inc. - Mergers & Acquisitions (M&A), Partnerships & Alliances and Investment Report Summary Marketline's BEENOS Inc. Mergers & Acquisitions (M&A), Partnerships & Alliances and Investments report includes business description, detailed reports on mergers and acquisitions (M&A), divestments, ca …
  • Heron Therapeutics Inc (HRTX)-医療機器分野:企業M&A・提携分析
    Summary Heron Therapeutics Inc (Heron), formerly A.P. Pharma, Inc., is a biotechnology company that uses its proprietary polymer-based drug delivery platform to develop novel, patient-focused therapeutic products for patients suffering from cancer and pain. Its proprietary Biochronomer technology is …
  • Somnomed Ltd (SOM):企業の財務・戦略的SWOT分析
    Summary Somnomed Ltd (SomnoMed) is a medical device company that develops, produces, commercializes and markets devices for the oral treatment of sleep-related disorders. The company’s products include Somnodent, an oral appliance for obstructive sleep apnea; and Somnobrux, a mouthguard that protect …
  • Mr. Price Group Ltd.
    Mr. Price Group Ltd. - Strategy, SWOT and Corporate Finance Report Summary Mr. Price Group Ltd. - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offerings …
  • Intarcia Therapeutics Inc-医療機器分野:企業M&A・提携分析
    Summary Intarcia Therapeutics Inc (Intarcia), formerly BioMedicines Inc, is a biopharmaceutical company that discovers, develops and commercializes drug therapies to reduce effects for chronic diseases. The company’s product candidate include ITCA 650, which is in Phase III clinical trial. Its ITCA …
  • Vectura Group Plc (VEC):医療機器:M&Aディール及び事業提携情報
    Summary Vectura Group Plc (Vectura) is a formulation and device business for inhaled airways products providing an integrated inhaled drug delivery platform. It develops inhalation products, to help patients suffering from airways diseases such as asthma, chronic obstructive pulmonary disease (COPD) …
  • BioDiem Ltd:企業の戦略的SWOT分析
    BioDiem Ltd - Strategic SWOT Analysis Review provides a comprehensive insight into the company’s history, corporate strategy, business structure and operations. The report contains a detailed SWOT analysis, information on the company’s key employees, key competitors and major products and services. …
  • African Phoenix Investments Ltd:企業の戦略・SWOT・財務分析
    African Phoenix Investments Ltd - Strategy, SWOT and Corporate Finance Report Summary African Phoenix Investments Ltd - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product …
  • Suncorp Group Ltd:戦略・SWOT・企業財務分析
    Suncorp Group Ltd - Strategy, SWOT and Corporate Finance Report Summary Suncorp Group Ltd - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offerings and c …
  • Biotec Pharmacon ASA (BIOTEC):医療機器:M&Aディール及び事業提携情報
    Summary Biotec Pharmacon ASA (Biotec Pharmacon) is a biopharmaceutical company that develops, manufactures and markets immune modulating compounds and cold adapted enzymes. The company provides products which are used in the areas of human medicine such as immunotherapy of cancer, general infection …
  • High Plains Power Inc:企業の戦略的SWOT分析
    High Plains Power Inc - Strategic SWOT Analysis Review provides a comprehensive insight into the company’s history, corporate strategy, business structure and operations. The report contains a detailed SWOT analysis, information on the company’s key employees, key competitors and major products and …
  • Brainsway Ltd (BRIN):医療機器:M&Aディール及び事業提携情報
    Summary Brainsway Ltd (Brainsway) is a medical device company that develops and markets transcranial magnetic stimulation systems and noninvasive medical device for treatment of neurological and psychopathological disorders. The company provides deep transcranial magnetic stimulation products. It of …
  • Yapi Merkezi Holding Inc.
    Yapi Merkezi Holding Inc. - Strategy, SWOT and Corporate Finance Report Summary Yapi Merkezi Holding Inc. - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service …
  • Haworth Inc:企業の戦略的SWOT分析
    Haworth Inc - Strategic SWOT Analysis Review provides a comprehensive insight into the company’s history, corporate strategy, business structure and operations. The report contains a detailed SWOT analysis, information on the company’s key employees, key competitors and major products and services. …
  • Fukuda Denshi Co Ltd (6960):医療機器:M&Aディール及び事業提携情報
    Summary Fukuda Denshi Co Ltd (Fukuda Denshi) is a medical device company, which develops, manufactures, and commercializes medical equipment including cardiology, patient monitoring, vascular screening and ultrasound systems. The company’s product portfolio includes electrocardiographs, stress tests …
  • Immune Pharmaceuticals Inc (IMNP):製薬・医療:M&Aディール及び事業提携情報
    Summary Immune Pharmaceuticals Inc (Immune Pharma), formerly EpiCept Corp is a drug development company that develops novel therapies for immunologic and inflammatory diseases. The company’s pipeline products include Bertilimumab and Nanocyclo. Its Bertilimumab is a human monoclonal antibody designe …
  • Acuity Brands Inc (AYI)-エネルギー分野:企業M&A・提携分析
    Summary Acuity Brands, Inc. (Acuity Brands) provides lighting and building management solutions and services. The company offers lighting solutions including devices such as luminaires, lighting controls, lighting components, power supplies, prismatic skylights, and integrated lighting systems. It a …
  • Supernus Pharmaceuticals Inc (SUPN):企業の財務・戦略的SWOT分析
    Supernus Pharmaceuticals Inc (SUPN) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and …
  • Bio-Path Holdings Inc (BPTH):医療機器:M&Aディール及び事業提携情報
    Summary Bio-Path Holdings Inc (Bio-Path) is a clinical stage biotechnology company that develops targeted therapies for acute myeloid leukemia (AML), chronic myeloid leukemia (CML) and other challenging cancers. The company provides products pipeline such as prexigebersen (Liposomal Grb2 Antisense) …
  • ALTANA AG:戦略・SWOT・企業財務分析
    ALTANA AG - Strategy, SWOT and Corporate Finance Report Summary ALTANA AG - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offerings and corporate actions …

◆H&Iグローバルリサーチ株式会社のお客様(例)◆